1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Longitudinal study of body mass index, dyslipidemia, hyperglycemia, and hypertension in 60,000 men and women in Sweden and Austria
- 2017
- Cohort profile : The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)
- 2016
- Interpretation of conventional survival analysis and competing risk analysis : An example of hypertension and prostate cancer
- 2015
- Metabolic risk score and cancer risk: pooled analysis of seven cohorts.
- 2014
- Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations.
- A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (me-can) collaborative study.
- Pooled cohort study on height and risk of cancer and cancer death
- Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580 000 subjects within the Me-Can project
- 2013
- Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can)
- Total Serum Cholesterol and Cancer Incidence in the Metabolic Syndrome and Cancer Project (Me-Can)